There is something of the tortoise about Intertek Group PLC (LSE:ITRK). The testing and inspection group rarely makes headlines, yet it has been steadily plodding ahead, and according to Bank of America, it is now looking sprightlier than its peers.
BofA has reinstated coverage with a “buy” and a price target of 5,990p, suggesting a 25% gain from current levels.
The case rests on three things: margins, cash and returns. Intertek’s profit margin is forecast to hit 18.6% by 2027, comfortably ahead of rivals such as Bureau Veritas and SGS.
Cash generation is equally strong, with free cash flow set to climb to £480 million by then, enough to fund acquisitions and still pay out a rising dividend. Returns on invested capital, a key gauge of efficiency, are also expected to accelerate to 25%, compared with an industry average nearer 20%.
The jewel in the crown is consumer testing, which accounts for about half of earnings. This covers everything from toys to textiles to electricals, including batteries and medical devices.
After a sluggish 2023, demand picked up last year and has kept pace in 2025, with Bank of America pencilling in 7.5% organic growth. Because consumer testing is Intertek’s highest-margin division, any sustained momentum here provides a powerful lift to group profits.
Some investors fret about its relatively high exposure to China, about 18% of revenues, at a time of shifting supply chains and tariff uncertainty. But the bank reckons the benefits of scale still outweigh the risks and notes Intertek’s footprint in other Asian markets such as Vietnam and India.
On valuation, Intertek looks inexpensive against its own history. Shares trade at 17 times expected 2026 earnings, a 20% discount to their ten-year average and below sector leaders. With dividend yields heading north of 4% by 2027, the tortoise may yet prove the better bet.
In afternoon trading, the shares were up 1.2% at 4,882p.